Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 12, Issue 10, Pages 7163-7185
Publisher
MDPI AG
Online
2011-10-21
DOI
10.3390/ijms12107163
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling
- (2011) Q. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting mitochondria for cancer therapy
- (2010) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
- (2010) F. Weinberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism☆
- (2009) Divya Pathania et al. ADVANCED DRUG DELIVERY REVIEWS
- Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells
- (2009) In-Sung Song et al. CARCINOGENESIS
- Phase I Trial of 2-Methoxyestradiol NanoCrystal Dispersion in Advanced Solid Malignancies
- (2009) A. J. Tevaarwerk et al. CLINICAL CANCER RESEARCH
- Protective role of cytosolic 2-cys peroxiredoxin in the TNF-α-induced apoptotic death of human cancer cells
- (2009) Joo Young Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- Activity of 2 methoxyestradiol (Panzem ® NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: A Hoosier Oncology Group trial
- (2009) Daniela Matei et al. GYNECOLOGIC ONCOLOGY
- Peroxiredoxin IV Protects Cells From Radiation-Induced Apoptosis in Head-and-Neck Squamous Cell Carcinoma
- (2009) Jung Je Park et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III
- (2009) You Hyun Noh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The peroxidase and peroxynitrite reductase activity of human erythrocyte peroxiredoxin 2
- (2008) Bruno Manta et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- How mitochondria produce reactive oxygen species
- (2008) Michael P. Murphy BIOCHEMICAL JOURNAL
- Necroptosis: A Specialized Pathway of Programmed Necrosis
- (2008) Lorenzo Galluzzi et al. CELL
- No death without life: vital functions of apoptotic effectors
- (2008) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Up-Regulation of Peroxiredoxin 1 in Lung Cancer and Its Implication as a Prognostic and Therapeutic Target
- (2008) J.-H. Kim et al. CLINICAL CANCER RESEARCH
- Mitochondrial peroxiredoxin 3 is rapidly oxidized in cells treated with isothiocyanates
- (2008) Kristin K. Brown et al. FREE RADICAL BIOLOGY AND MEDICINE
- Elesclomol induces cancer cell apoptosis through oxidative stress
- (2008) J. R. Kirshner et al. MOLECULAR CANCER THERAPEUTICS
- Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury
- (2008) Elizabeth Murphy et al. PHYSIOLOGICAL REVIEWS
- Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling
- (2008) J. C. Juarez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondria in cancer cells: what is so special about them?
- (2008) Vladimir Gogvadze et al. TRENDS IN CELL BIOLOGY
- Reactive Oxygen Species May Have Antitumor Activity in Metastatic Melanoma
- (2007) Rabiya S. Tuma JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More